Evaxion Biotech A/S develops novel immunotherapies to treat various cancers, bacterial diseases, and viral infections suing proprietary AI platforms (PIONEER, EDEN, and RAVENTM). The company's drug candidates include EVX-01, EVX-02, and EVX-03. Evaxion Biotech A/S has collaboration agreements with the National Center at Herlev Hospital, the Department of Health Technology at Danish Technical University, and other institutions. Evaxion Biotech A/S was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
What is Evaxion Biotech A's quote symbol?
What is the 52 week high and low for Evaxion Biotech A (NASDAQ: EVAX)?
How much is Evaxion Biotech A stock worth today?
How much is Evaxion Biotech A's stock price per share?
What is Evaxion Biotech A's Market Cap?